346 related articles for article (PubMed ID: 30026867)
41. Cyr61/CCN1 is regulated by Wnt/β-catenin signaling and plays an important role in the progression of hepatocellular carcinoma.
Li ZQ; Ding W; Sun SJ; Li J; Pan J; Zhao C; Wu WR; Si WK
PLoS One; 2012; 7(4):e35754. PubMed ID: 22540002
[TBL] [Abstract][Full Text] [Related]
42. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
43. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
44. Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma.
Yang T; Cai SY; Zhang J; Lu JH; Lin C; Zhai J; Wu MC; Shen F
PLoS One; 2012; 7(6):e39668. PubMed ID: 22761862
[TBL] [Abstract][Full Text] [Related]
45. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract][Full Text] [Related]
46. Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma.
Li P; Cao Y; Li Y; Zhou L; Liu X; Geng M
Int J Clin Exp Pathol; 2014; 7(6):3190-5. PubMed ID: 25031739
[TBL] [Abstract][Full Text] [Related]
47. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
[TBL] [Abstract][Full Text] [Related]
48. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
49. Wnt signaling in liver cancer.
Takigawa Y; Brown AM
Curr Drug Targets; 2008 Nov; 9(11):1013-24. PubMed ID: 18991612
[TBL] [Abstract][Full Text] [Related]
50. Wnt-promoted Isl1 expression through a novel TCF/LEF1 binding site and H3K9 acetylation in early stages of cardiomyocyte differentiation of P19CL6 cells.
Lu H; Li Y; Wang Y; Liu Y; Wang W; Jia Z; Chen P; Ma K; Zhou C
Mol Cell Biochem; 2014 Jun; 391(1-2):183-92. PubMed ID: 24610003
[TBL] [Abstract][Full Text] [Related]
51. miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.
Jiang C; Yu M; Xie X; Huang G; Peng Y; Ren D; Lin M; Liu B; Liu M; Wang W; Kuang M
Oncol Rep; 2017 Oct; 38(4):2351-2359. PubMed ID: 28849121
[TBL] [Abstract][Full Text] [Related]
52. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
53. Neuroglobin Regulates Wnt/β-Catenin and NFκB Signaling Pathway through Dvl1.
Xun Y; Li Z; Tang Y; Yang M; Long S; Shu P; Li J; Xiao Y; Tang F; Wei C; Liu N; Xiang S
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041403
[TBL] [Abstract][Full Text] [Related]
54. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
55. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
[TBL] [Abstract][Full Text] [Related]
56. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
[TBL] [Abstract][Full Text] [Related]
57. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
58. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
[TBL] [Abstract][Full Text] [Related]
59. WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
Luo X; Liu Y; Ma S; Liu L; Xie R; Wang S
Dig Dis Sci; 2019 Sep; 64(9):2591-2599. PubMed ID: 30877610
[TBL] [Abstract][Full Text] [Related]
60. The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma.
Li C; Wu W; Ding H; Li Q; Xie K
Mol Med Rep; 2018 Jun; 17(6):7645-7651. PubMed ID: 29620186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
